FDA approves new treatment for active psoriatic arthritis

June 28, 2006

There's encouraging news for the approximately one million women and men who suffer from psoriatic arthritis. Today, the U.S. Food and Drug Administration approved Remicade to reduce the signs and symptoms of active arthritis in patients with psoriatic arthritis.